Share on LinkedInShare on LinkedIn

ARTICLE · 14 MARCH 2013

Will FTC Chairman Leibowitz’s Departure Change The Enforcement Landscape?

After three years at the helm of the Federal Trade Commission, Chairman Jon Leibowitz stepped down.

United StatesAntitrust/Competition Law

After three years at the helm of the Federal Trade Commission (FTC), Chairman Jon Leibowitz stepped down. Without a doubt Chairman Leibowitz has been a visible and relentless advocate for restricting pay-for-day or reverse payment generic pharmaceutical patent dispute settlements and for expanding the reach of Section 5 of the Federal Trade Commission Act, 15 U.S.C. §45.

FTC v. Watson, which is set for oral argument on March 25, 2013 before the U.S. Supreme Court, should decide the antitrust standard applicable to reverse payment settlements. There, the FTC is arguing that reverse payment agreements should be treated as presumptively unlawful because, according to the FTC's brief in the Supreme Court, they closely resemble the sort of horizontal agreements that have previously been condemned under the antitrust laws. The standard applied in most circuits is the "scope of the patent" test—reverse payment settlements are lawful as long as the settlement does not exceed

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from